These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25845673)

  • 1. The Inflammatory Hypothesis of Atrial Fibrillation: Diagnostic Marker, Therapeutic Target, or Innocent Bystander?
    Witt C; Kapa S
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):641-3. PubMed ID: 25845673
    [No Abstract]   [Full Text] [Related]  

  • 2. Galectin-3: A potential new target for upstream therapy of atrial fibrillation.
    He B; Huang B; Lu Z; He W; Jiang H
    Int J Cardiol; 2016 Jan; 203():1131-2. PubMed ID: 26608016
    [No Abstract]   [Full Text] [Related]  

  • 3. The Association of Serum Galectin-3 Levels with Atrial Electrical and Structural Remodeling.
    Yalcin MU; Gurses KM; Kocyigit D; Canpinar H; Canpolat U; Evranos B; Yorgun H; Sahiner ML; Kaya EB; Hazirolan T; Tokgozoglu L; Oto MA; Ozer N; Guc D; Aytemir K
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):635-40. PubMed ID: 25684038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications.
    Clementy N; Piver E; Bisson A; Andre C; Bernard A; Pierre B; Fauchier L; Babuty D
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3 and atrial fibrillation.
    Duygu H
    Int J Cardiol; 2017 Feb; 229():1. PubMed ID: 27986283
    [No Abstract]   [Full Text] [Related]  

  • 6. Galectin-3 in Atrial Fibrillation: A Novel Marker of Atrial Remodeling or Just Bystander?
    Kornej J; Schmidl J; Bollmann A
    Am J Cardiol; 2015 Jul; 116(1):163. PubMed ID: 25956621
    [No Abstract]   [Full Text] [Related]  

  • 7. Galectin-3 in atrial fibrillation: Simple bystander, player or both?
    Lippi G; Cervellin G; Sanchis-Gomar F
    Clin Biochem; 2015 Aug; 48(12):818-22. PubMed ID: 25952321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation.
    Hernández-Romero D; Vílchez JA; Lahoz Á; Romero-Aniorte AI; Jover E; García-Alberola A; Jara-Rubio R; Martínez CM; Valdés M; Marín F
    Sci Rep; 2017 Jan; 7():40378. PubMed ID: 28079145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New onset atrial fibrillation is associated with elevated galectin-3 levels.
    Chen D; Procter N; Goh V; Liu S; Chua SJ; Assadi-Khansari B; Stewart S; Horowitz JD; Sverdlov AL; Ngo DT
    Int J Cardiol; 2016 Nov; 223():48-49. PubMed ID: 27529590
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between peripheral plasma markers and left atrial anatomy in patients with atrial fibrillation.
    Nedios S; Seewöster T; Lip GH; Husser D; Hindricks G; Bollmann A; Kornej J
    Int J Cardiol; 2016 Jan; 203():621-3. PubMed ID: 26580343
    [No Abstract]   [Full Text] [Related]  

  • 11. Galectin-3 and risk of atrial fibrillation: A systematic review and meta-analysis.
    Gong M; Cheung A; Wang QS; Li G; Goudis CA; Bazoukis G; Lip GYH; Baranchuk A; Korantzopoulos P; Letsas KP; Tse G; Liu T
    J Clin Lab Anal; 2020 Mar; 34(3):e23104. PubMed ID: 31917884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to the letter to editor: Galectin-3 and atrial fibrillation.
    Sverdlov AL; Ngo DT
    Int J Cardiol; 2017 Feb; 229():2. PubMed ID: 27956319
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of persistent atrial fibrillation.
    Jalife J
    Curr Opin Cardiol; 2014 Jan; 29(1):20-7. PubMed ID: 24281345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply: To PMID 25604929.
    Kocyigit D; Gurses KM
    Am J Cardiol; 2015 Jul; 116(1):164. PubMed ID: 25956625
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of persistent atrial fibrillation on serum galectin-3 levels.
    Gurses KM; Yalcin MU; Kocyigit D; Canpinar H; Evranos B; Yorgun H; Sahiner ML; Kaya EB; Ozer N; Tokgozoglu L; Oto MA; Guc D; Aytemir K
    Am J Cardiol; 2015 Mar; 115(5):647-51. PubMed ID: 25604929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Upstream Approaches to Prevent Atrial Fibrillation Perpetuation.
    Jalife J
    Heart Fail Clin; 2016 Apr; 12(2):309-22. PubMed ID: 26968673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HOMOCYSTEINE AS A PROGNOSTIC MARKER OF ATRIAL REMODELING AND CLINICAL PICTURE IN PATIENTS WITH PAROXYSMAL AND PERSISTENT FORMS OF ATRIAL FIBRILLATION].
    Snezhitsky VA; Yatskevich ES; Doroshenko EM; Smirnov VY; Dolgoshey TS; Rubinsky AY
    Klin Med (Mosk); 2016; 94(1):16-22. PubMed ID: 27172716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation: a progressive atrial myopathy or a distinct disease?
    Kallergis EM; Goudis CA; Vardas PE
    Int J Cardiol; 2014 Feb; 171(2):126-33. PubMed ID: 24388634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrical remodeling in human atrial fibrillation.
    Lee HC
    Chin Med J (Engl); 2013 Jun; 126(12):2380-3. PubMed ID: 23786958
    [No Abstract]   [Full Text] [Related]  

  • 20. Transthoracic echocardiographic backscatter-based assessment of left atrial remodeling involving left atrial and ventricular fibrosis in patients with atrial fibrillation.
    Sasaki N; Okumura Y; Watanabe I; Nagashima K; Sonoda K; Kogawa R; Takahashi K; Iso K; Ohkubo K; Nakai T; Hiro T; Hirayama A
    Int J Cardiol; 2014 Oct; 176(3):1064-6. PubMed ID: 25129276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.